Opioid detox for Lantana — fentanyl-era protocols, buprenorphine done right.

RECO Island's Delray Beach campus sits 11 miles south of Lantana — 18 minutes down Federal Highway, closer via A1A when the drawbridge cooperates. Detox and residential treatment happen on the same campus, so Lantana clients from Hypoluxo Island, Manalapan, or Old Town do not face a third-party handoff during the buprenorphine stabilization window. COWS-guided induction, fentanyl-era micro-induction protocols when indicated, and 24/7 nursing coverage from a small-census, physician-led program.

Lantana sits on the Intracoastal between Delray Beach and West Palm, with Hypoluxo Island and Manalapan spilling east onto the barrier islands and Old Town Lantana holding the mainland’s older grid. From most addresses here, RECO Island’s Delray Beach campus is 18 minutes down Federal Highway — often less via A1A when the drawbridge cooperates. For residents facing opioid dependence, that 11-mile radius matters clinically: it means detox and residential treatment within one contiguous stay, without a highway transfer during the worst of withdrawal.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs have functionally rewritten the opioid withdrawal timeline. Where heroin or oxycodone withdrawal historically peaked at 48-72 hours on a predictable curve, fentanyl-exposed patients now present with earlier onset, sharper acute intensity, and — the clinical problem that changes protocols — a prolonged tail driven by fentanyl’s lipophilicity and slow release from adipose tissue. The old buprenorphine induction window (12-24 hours after last opioid use, at moderate withdrawal) frequently produces precipitated withdrawal in fentanyl users, because residual fentanyl still occupies mu receptors when buprenorphine’s higher affinity displaces it.

RECO Island’s opioid detox protocol reflects this shift. For patients with recent fentanyl exposure, physicians extend the pre-induction window, use COWS scoring rather than time-based rules to gate the first dose, and — when clinically indicated — deploy low-dose (Bernese) or micro-induction protocols that overlap buprenorphine with residual full agonist to avoid precipitated withdrawal entirely. Comfort medications carry the client through the extended window without the traditional wait-it-out approach that fentanyl-era patients often cannot tolerate.

Twenty-four-hour nursing coverage means COWS scores are taken every four hours during the acute phase, not once a shift, and a physician is available for order changes around the clock. This is the staffing level opioid detox requires when the drug supply has changed underneath the diagnosis.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale scores eleven observable and reported symptoms: resting pulse, sweating, restlessness, pupil size, bone or joint aches, runny nose or tearing, GI upset, tremor, yawning, anxiety or irritability, and gooseflesh skin. Total scores classify withdrawal as mild (5-12), moderate (13-24), moderately severe (25-36), or severe (37+). Buprenorphine induction is typically gated at COWS 11 or higher to reduce precipitated withdrawal risk, though for high-tolerance fentanyl users we frequently wait for COWS 13-15 before the first dose.

Standard induction starts at 2-4 mg sublingual buprenorphine/naloxone, with a second 2-4 mg dose 1-2 hours later if withdrawal has not resolved. Day-one totals commonly reach 8-12 mg; by day two or three most patients stabilize on 8-16 mg daily. Patients with severe fentanyl tolerance may require the upper end of this range or brief agonist supplementation during the first 48 hours.

Adjunctive medications during induction include clonidine 0.1-0.2 mg every 6-8 hours for autonomic symptoms with blood pressure monitoring, loperamide for diarrhea, ondansetron 4-8 mg for nausea, hydroxyzine or trazodone for sleep, and NSAIDs for myalgia. This is the medication stack that makes the withdrawal window survivable while buprenorphine reaches steady state.

Buprenorphine, methadone, or naltrexone — the MAT decision

Three medications carry Grade A evidence for opioid use disorder maintenance, and the choice among them shapes the next twelve months of recovery. Buprenorphine (Suboxone, Subutex, Sublocade extended-release injection) is a partial mu agonist with a ceiling effect that limits overdose risk; it can be prescribed office-based and is the default for most patients leaving detox with an outpatient MAT plan.

Methadone is a full mu agonist with the strongest evidence base for treatment retention, but it can only be dispensed through federally licensed opioid treatment programs with daily dosing initially. It is typically indicated for patients with long, severe use histories, failed buprenorphine trials, or lifestyles compatible with an OTP model.

Extended-release naltrexone (Vivitrol) is a full mu antagonist administered as a monthly intramuscular injection. It requires 7-10 days completely opioid-free before the first dose — a bar harder to clear with fentanyl than with shorter-acting opioids. It fits patients who prefer a non-agonist option, are motivated by monthly rather than daily medication, or face employment situations where buprenorphine is not workable. The medication decision is made with the client during the detox stay using shared decision-making, informed by prior treatment response, current clinical picture, discharge geography, and insurance coverage.

Naloxone education and the safety net

Every client leaving RECO Island’s opioid detox receives naloxone (intranasal Narcan or intramuscular formulation), naloxone administration training, and family training in overdose recognition. This is not an add-on service. It is part of the medical standard of care for opioid use disorder discharge.

The rationale is unambiguous: overdose mortality is highest in the 2-4 weeks after any period of abstinence — detox, incarceration, or hospitalization — because opioid tolerance drops rapidly while return-to-use risk remains. A pre-detox dose that a patient tolerated may be fatal post-detox. Fentanyl compounds this because a typical bag from the same supplier can vary in potency dramatically. Naloxone in the home, in the car, and known-to-family is the intervention that closes the gap between relapse and rescue.

Discharging clients are connected to community naloxone distribution programs in Palm Beach County so kits can be refilled without prescription hurdles, and families are counseled on Good Samaritan law and 911 response.

What to expect on your first day

Admission begins with a brief phone assessment — insurance verification, clinical intake, and confirmation that opioid detox is the clinically appropriate level of care under ASAM Criteria dimensions (acute intoxication/withdrawal potential, biomedical conditions, emotional/behavioral/cognitive, readiness to change, relapse potential, recovery environment). A driver or family member can bring the client directly; ambulance is not required for a planned admission.

On arrival: medical history and physical, urine drug screen, comprehensive metabolic panel, ECG if clinically indicated, and initial COWS scoring. The admitting physician writes detox orders — comfort medications, buprenorphine induction timing, adjunctive supports. A nurse remains with the client through the initial withdrawal window. By the second day, most clients are stable on buprenorphine or in extended pre-induction with comfort medications working. Group and individual programming — CBT, MI, relapse prevention — begins as clients are ready to participate.

Insurance and admissions from Lantana

RECO Island is in-network with or accepts single-case agreements from Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Verification is same-day; most patients admit within 24 hours of the initial call. For Lantana residents, the 11-mile drive from Hypoluxo Island, Manalapan, Ocean Ridge, or Old Town Lantana is 18 minutes down Federal Highway — often less via A1A off-peak.

Because detox flows directly into residential treatment on the same campus, there is no discharge-then-readmit gap, no third-party transfer, and no waitlist between levels of care. That continuity — physician-led, small-census, and geographically contained — is the operational reason completion rates for the full detox-through-residential episode look the way they do.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.